Abstract
The application of nanotechnology in biology and medicine is generally termed as nanomedicine which reforms the strategic platforms of the modern healthcare system associated with diagnosis and therapy of different diseases. Since past decades, several research groups including ours demonstrated the diverse biomedical applications of different inorganic nanoparticles. Among these nanomaterials, graphene oxide (GO) nanoparticles are of great attraction for their potent applications in angiogenesis as well as cancer therapy due to its unique physicochemical and biological properties such as large surface area, high drug loading efficacy, biocompatibility, biodegradability, etc. This book chapter illustrates the overview of recent applications of GO in angiogenesis including pro-angiogenic activity, anti-angiogenic activity and wound healing potential. Moreover, the therapeutic (anticancer activity, drug/gene delivery, photothermal/immuno therapy) and bio-imaging applications of GO for different cancer diseases are also described in a concise manner. Additionally, in view of future clinical applications, pharmacokinetics, toxicity and clearance studies of GO are briefly demonstrated. Finally, this book chapter provides the global market overview along with challenges and future directions of GO in biomedical applications.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- A549:
-
Human alveolar adenocarcinoma epithelial cell line
- Ab:
-
Antibody
- ADM:
-
Acellular dermal matrix
- AIE:
-
Aggregation-induced emission
- APCs:
-
Antigen-presenting cells
- B16:
-
Murine melanoma cells
- Bcl-2:
-
B-cell lymphoma-2
- bFGF:
-
Basic fibroblast growth factor
- BSA:
-
Bovine serum albumin
- CAD:
-
Cis-aconitic anhydride-modified doxorubicin
- CAM:
-
Chick chorioallantoic membrane
- CEA:
-
Chick embryo angiogenesis
- CMC:
-
Carboxymethylcellulose
- CpG:
-
Cytosine-phosphate-guanine
- CS-PVA:
-
Chitosan-polyvinyl alcohol
- CT:
-
Computed tomography
- Cx43:
-
Connexin43
- DCs:
-
Dendritic cells
- DDS:
-
Drug delivery system
- DIM:
-
Diindolylmethane
- DNA:
-
Deoxyribonucleic acid
- DOX:
-
Doxorubicin
- E. coli :
-
Escherichia coli
- ECM:
-
Extracellular matrix
- EGFP:
-
Enhanced green fluorescence protein
- eNOS:
-
Endothelial nitric oxide synthase
- EPR:
-
Enhanced permeability and retention
- FA:
-
Folic acid
- FDA:
-
Food and drug administration
- fGO:
-
Functionalized graphene oxide
- FITC:
-
Fluorescein isothiocyanate
- FSHR:
-
Follicle-stimulating hormone receptor
- GelMA:
-
Methacrylated gelatin
- GF:
-
Graphene foams
- GIC:
-
Graphene intercalation compounds
- GO:
-
Graphene oxide
- GPD:
-
GO-PEG-PAMAM
- H2SO4:
-
Sulphuric acid
- HBD:
-
Heparin-binding domain
- HDAC:
-
Histone deacetylases
- HeLa:
-
Human cervical cancer cells
- HGF:
-
Hepatocyte growth factor
- HNO3:
-
Nitric acid
- HUVECs:
-
Human umbilical vein endothelial cells
- IDO:
-
Immune checkpoint overexpressed in tumours
- IL1β:
-
Interleukin-1 beta
- IL6:
-
Interleukin 6
- IR800:
-
Infrared 800
- IUPAC:
-
International union of pure and applied chemistry
- KClO3:
-
Potassium chlorate
- LDI:
-
Laser Doppler imaging
- LHT7:
-
Low molecular weight heparin
- LSECs:
-
Liver sinusoidal endothelial cells
- MBA-MB-231:
-
Human breast cancer cell line
- MCF-7:
-
Human breast cancer cell line
- MCP-1:
-
Monocyte chemotactic protein 1
- MDR:
-
Multidrug-resistant
- MIA PaCA-2:
-
Human pancreatic carcinoma
- MMP-9:
-
Matrix metallopeptidase 9
- MRI:
-
Magnetic resonance imaging
- MSCs:
-
Mesenchymal stem cells
- NIR:
-
Near-infrared
- NO:
-
Nitric oxide
- OVA:
-
Ovalbumin
- PAACA:
-
Poly(acryloyl-6-aminocaproic acid)
- PAH:
-
Polyallylamine hydrochloride
- PAMAM:
-
Polyamidoamine dendrimer
- PDDA:
-
Poly(diallyldimethylammonium chloride)
- PDGF:
-
Platelet-derived growth factor
- pDNA:
-
Plasmid DNA
- PEG:
-
Polyethylene glycol
- PEI:
-
Polyethyleneimine
- PET:
-
Positron emission tomography
- PGO:
-
Porphyrin graphene oxide
- PI:
-
Propidium iodide
- PMAA:
-
Poly(methacrylic acid)
- PPa:
-
Pyropheophorbide-a
- PTX:
-
Paclitaxel
- PVP:
-
Poly N-vinylpyrrolidone
- RAW 264.7:
-
Murine macrophage cell line
- RES:
-
Reticuloendothelial system
- rGO:
-
Reduced graphene oxide
- RNA:
-
Ribonucleic acid
- ROS:
-
Reactive oxygen species
- S. aureus :
-
Staphylococcus aureus
- SCC-7:
-
Mouse head and neck carcinoma cell line
- shRNA:
-
Short hairpin RNA
- SiHa:
-
Cervical squamous cancer cells
- siRNA:
-
Short interfering RNA
- SPION:
-
Superparamagnetic iron oxide nanoparticles
- SRGO:
-
Sorafenib reduced graphene oxide
- TiO2:
-
Titanium dioxide
- TLR:
-
Toll-like receptor
- TNFα:
-
Tumour necrosis factor alpha
- U118:
-
Human brain glioma cells
- U87:
-
Human primary glioblastoma cell line
- UCNPs:
-
Upconversion nanoparticles
- Ure B:
-
Urease B
- VAR:
-
Peptide probe
- VEGF:
-
Vascular endothelial growth factor
- ZnO:
-
Zinc oxide
- ZnPc:
-
Zn(II)-phthalocyanine
References
Afarideh B, Rajabibazl M, Omidi M et al (2018) Anticancer activity of graphene oxide/5-FU on CT26 Ds-Red adenocarcinoma cell line. Orient J Chem 34:2002
Ahmad MW, Xu W, Kim SJ et al (2015) Potential dual imaging nanoparticle: Gd2O3 nanoparticle. Sci Rep 5:8549
Akhavan O, Ghaderi E, Aghayee S et al (2012) The use of a glucose-reduced graphene oxide suspension for photothermal cancer therapy. J Mater Chem 22:13773–13781
Arvizo RR, Rana S, Miranda OR et al (2011) Mechanism of anti-angiogenic property of gold nanoparticles: role of nanoparticle size and surface charge. Nanomedicine 7:580–587
Bae YH, Park K (2011) Targeted drug delivery to tumors: myths, reality and possibility. J Control Release 153:198–205
Bansal A, Zhang Y (2014) Photocontrolled nanoparticle delivery systems for biomedical applications. Acc Chem Res 47:3052–3060
Bartczak D, Muskens OL, Sanchez-Elsner T et al (2013) Manipulation of in vitro angiogenesis using peptide-coated gold nanoparticles. ACS Nano 7:5628–5636
Barui AK, Veeriah V, Mukherjee S et al (2012) Zinc oxide nanoflowers make new blood vessels. Nanoscale 4:7861–7869
Bergers G, Hanahan D (2008) Modes of resistance to anti-angiogenic therapy. Nat Rev Cancer 8:592–603
Bikfalvi A, Bicknell R (2002) Recent advances in angiogenesis, anti-angiogenesis and vascular targeting. Trends Pharmacol Sci 23:576–582
Boehm H-P, Setton R, Stumpp E (1994) Nomenclature and terminology of graphite intercalation compounds. Pure Appl Chem 66:1893–1901
Borghaei H, Smith MR, Campbell KS (2009) Immunotherapy of cancer. Eur J Pharmacol 625:41–54
Brodie BC (1859) On the atomic weight of graphite. Philos Trans R Soc London 149:249–259
Byun J (2015) Emerging frontiers of graphene in biomedicine. J Microbiol Biotechnol 25:145–151
Caruso F, Hyeon T, Rotello VM (2012) Nanomedicine. Chem Soc Rev 41:2537–2538
Chang Y, Yang ST, Liu JH et al (2011) In vitro toxicity evaluation of graphene oxide on A549 cells. Toxicol Lett 200:201–210
Chaudhuri P, Harfouche R, Soni S et al (2010) Shape effect of carbon nanovectors on angiogenesis. ACS Nano 4:574–582
Chen Y, Chen HR, Shi JL (2014) Inorganic nanoparticle-based drug codelivery nanosystems to overcome the multidrug resistance of cancer cells. Mol Pharm 11:2495–2510
Chen X, Liu L, Jiang C (2016) Charge-reversal nanoparticles: novel targeted drug delivery carriers. Acta Pharm Sin B 6:261–267
Cheon YA, Bae JH, Chung BG (2016) Reduced graphene oxide nanosheet for chemo-photothermal therapy. Langmuir 32:2731–2736
Chidambaram M, Manavalan R, Kathiresan K (2011) Nanotherapeutics to overcome conventional cancer chemotherapy limitations. J Pharm Pharm Sci 14:67–77
Cho K, Wang X, Nie S et al (2008) Therapeutic nanoparticles for drug delivery in cancer. Clin Cancer Res 14:1310–1316
Cho WS, Kang BC, Lee JK et al (2013) Comparative absorption, distribution, and excretion of titanium dioxide and zinc oxide nanoparticles after repeated oral administration. Part Fibre Toxicol 10:9
Chu J, Shi P, Yan W et al (2018) PEGylated graphene oxide-mediated quercetin-modified collagen hybrid scaffold for enhancement of MSCs differentiation potential and diabetic wound healing. Nanoscale 10:9547–9560
Cong HP, Wang P, Yu SH (2013) Stretchable and self-healing graphene oxide-polymer composite hydrogels: a dual-network design. Chem Mater 25:3357–3362
Cotton FA, Wilkinsion G (1972) Advanced inorganc chemistry, 3rd edn. Wiley, Chichester, ISBN: 0-471-17560-9
Dai L (2006) Carbon nanotechnology recent developments in chemistry, physics, materials science and device applications. Elsevier, Amsterdam, ISBN-10: 044451855X
Danhier F, Feron O, Preat V (2010) To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J Control Release 148:135–146
Das S, Singh S, Dowding JM et al (2012) The induction of angiogenesis by cerium oxide nanoparticles through the modulation of oxygen in intracellular environments. Biomaterials 33:7746–7755
Deb A, Andrews NG, Raghavan V (2018) Natural polymer functionalized graphene oxide for co-delivery of anticancer drugs: in-vitro and in-vivo. Int J Biol Macromol 113:515–525
Di Santo R, Digiacomo L, Palchetti S et al (2019) Microfluidic manufacturing of surface-functionalized graphene oxide nanoflakes for gene delivery. Nanoscale 11:2733–2741
Draz MS, Fang BA, Zhang P et al (2014) Nanoparticle-mediated systemic delivery of siRNA for treatment of cancers and viral infections. Theranostics 4:872–892
Dreyer DR, Ruoff RS, Bielawski CW (2010) From conception to realization: an historial account of graphene and some perspectives for its future. Angew Chem 49:9336–9344
Enterkin JA, Poeppelmeier KR, Marks LD (2011) Oriented catalytic platinum nanoparticles on high surface area strontium titanate nanocuboids. Nano Lett 11:993–997
Erathodiyil N, Ying JY (2011) Functionalization of inorganic nanoparticles for bioimaging applications. Acc Chem Res 44:925–935
Falkowski P, Scholes RJ, Boyle EE et al (2000) The global carbon cycle: a test of our knowledge of earth as a system. Science 290:291–296
Fan ZJ, Liu B, Wang J et al (2014) A novel wound dressing based on Ag/Graphene polymer hydrogel: effectively kill bacteria and accelerate wound healing. Adv Funct Mater 24:3933–3943
Feng L, Liu Z (2011) Graphene in biomedicine: opportunities and challenges. Nanomedicine (Lond) 6:317–324
Feng L, Zhang S, Liu Z (2011) Graphene based gene transfection. Nanoscale 3:1252–1257
Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1:27–31
Geim AK, Novoselov KS (2007) The rise of graphene. Nat Mater 6:183–191
Gu Y, Guo Y, Wang C et al (2017) A polyamidoamne dendrimer functionalized graphene oxide for DOX and MMP-9 shRNA plasmid co-delivery. Mater Sci Eng C Mater Biol Appl 70:572–585
Gulzar A, Xu J, Yang D et al (2018) Nano-graphene oxide-UCNP-Ce6 covalently constructed nanocomposites for NIR-mediated bioimaging and PTT/PDT combinatorial therapy. Dalton Trans (Cambridge, England) 2003(47):3931–3939
Gurunathan S, Lee KJ, Kalishwaralal K et al (2009) Antiangiogenic properties of silver nanoparticles. Biomaterials 30:6341–6350
Gurunathan S, Han JW, Eppakayala V et al (2013) Green synthesis of graphene and its cytotoxic effects in human breast cancer cells. Int J Nanomedicine 8:1015–1027
Hamidi M, Azadi A, Rafiei P et al (2013) A pharmacokinetic overview of nanotechnology-based drug delivery systems: an ADME-oriented approach. Crit Rev Ther Drug Carrier Syst 30:435–467
Hijaz M et al (2016) Folic acid tagged nanoceria as a novel therapeutic agent in ovarian cancer. BMC Cancer 16:220
Holgate ST (2010) Exposure, uptake, distribution and toxicity of nanomaterials in humans. J Biomed Nanotechnol 6:1–19
Hong H, Zhang Y, Engle JW et al (2012) In vivo targeting and positron emission tomography imaging of tumor vasculature with Ga-66-labeled nano-graphene. Biomaterials 33:4147–4156
Hu H, You YY, He LZ et al (2015) The rational design of NAMI-A-loaded mesoporous silica nanoparticles as antiangiogenic nanosystems. J Mater Chem B 3:6338–6346
Huang C, Wu J, Jiang W et al (2018) Amphiphilic prodrug-decorated graphene oxide as a multi-functional drug delivery system for efficient cancer therapy. Mater Sci Eng C Mater Biol Appl 89:15–24
Jaleel JA, Sruthi S, Pramod K (2017) Reinforcing nanomedicine using graphene family nanomaterials. J Control Release 255:218–230
Jasim DA, Menard-Moyon C, Begin D et al (2015) Tissue distribution and urinary excretion of intravenously administered chemically functionalized graphene oxide sheets. Chem Sci 6:3952–3964
Jaworski S, Sawosz E, Kutwin M et al (2015) In vitro and in vivo effects of graphene oxide and reduced graphene oxide on glioblastoma. Int J Nanomedicine 10:1585–1596
Jong WHD, Borm PJ (2008) Drug delivery and nanoparticles:applications and hazards. Int J Nanomedicine 3:133–149
Josefsen LB, Boyle RW (2012) Unique diagnostic and therapeutic roles of porphyrins and phthalocyanines in photodynamic therapy, imaging and theranostics. Theranostics 2:916–966
Kang K, Lim DH, Choi IH et al (2011) Vascular tube formation and angiogenesis induced by polyvinylpyrrolidone-coated silver nanoparticles. Toxicol Lett 205:227–234
Kang S, Kim KM, Son Y et al (2019) Graphene oxide quantum dots derived from coal for bioimaging: facile and green approach. Sci Rep 9:4101
Khot LR, Sankaran S, Maja JM et al (2012) Applications of nanomaterials in agricultural production and crop protection: a review. Crop Prot 35:64–70
Kiew SF, Kiew LV, Lee HB et al (2016) Assessing biocompatibility of graphene oxide-based nanocarriers: a review. J Control Release 226:217–228
Kim JY, Shim G, Choi HW et al (2012) Tumor vasculature targeting following co-delivery of heparin-taurocholate conjugate and suberoylanilide hydroxamic acid using cationic nanolipoplex. Biomaterials 33:4424–4430
Krishnamachari Y, Geary SM, Lemke CD et al (2011) Nanoparticle delivery systems in cancer vaccines. Pharm Res 28:215–236
Kumar S, Chatterjee K (2016) Comprehensive review on the use of graphene-based substrates for regenerative medicine and biomedical devices. ACS Appl Mater Interfaces 8:26431–26457
Lai PX, Chen CW, Wei SC et al (2016) Ultrastrong trapping of VEGF by graphene oxide: anti-angiogenesis application. Biomaterials 109:12–22
Leteba GM, Lang CI (2013) Synthesis of bimetallic platinum nanoparticles for biosensors. Sensors (Basel) 13:10358–10369
Li SD, Huang L (2008) Pharmacokinetics and biodistribution of nanoparticles. Mol Pharm 5:496–504
Li SH, Aphale AN, Macwan IG et al (2012) Graphene oxide as a quencher for fluorescent assay of amino acids, peptides, and proteins. ACS Appl Mater Interfaces 4:7068–7074
Li B, Yang J, Huang Q et al (2013) Biodistribution and pulmonary toxicity of intratracheally instilled graphene oxide in mice. NPG Asia Materials 5:e44
Li Y, Dong H, Li Y et al (2015a) Graphene-based nanovehicles for photodynamic medical therapy. Int J Nanomedicine 10:2451–2459
Li Z, Wang H, Yang B et al (2015b) Three-dimensional graphene foams loaded with bone marrow derived mesenchymal stem cells promote skin wound healing with reduced scarring. Mater Sci Eng C Mater Biol Appl 57:181–188
Li QR, Jiao JB, Li LL et al (2017) Graphene oxide-enhanced cytoskeleton imaging and mitosis tracking. Chem Commun (Camb) 53:3373–3376
Liao KH, Lin YS, Macosko CW et al (2011) Cytotoxicity of graphene oxide and graphene in human erythrocytes and skin fibroblasts. ACS Appl Mater Interfaces 3:2607–2615
Lin S, Ruan J, Wang S (2019) Biosynthesized of reduced graphene oxide nanosheets and its loading with paclitaxel for their anti cancer effect for treatment of lung cancer. J Photochem Photobiol B 191:13–17
Liu Y, Yu D, Zeng C et al (2010) Biocompatible graphene oxide-based glucose biosensors. Langmuir 26:6158–6160
Liu JH, Yang ST, Wang HF et al (2012) Effect of size and dose on the biodistribution of graphene oxide in mice. Nanomedicine 7:1801–1812
Liu P, Wang S, Liu X et al (2018) Platinated graphene oxide: a nanoplatform for efficient gene-chemo combination cancer therapy. Eur J Pharm Sci 21:319–329
Lohse SE, Murphy CJ (2012) Applications of colloidal inorganic nanoparticles: from medicine to energy. J Am Chem Soc 134:15607–15620
Lu CH, Zhu CL, Li J et al (2010) Using graphene to protect DNA from cleavage during cellular delivery. Chem Commun 46:3116–3118
Lu B, Li T, Zhao H et al (2012) Graphene-based composite materials beneficial to wound healing. Nanoscale 4:2978–2982
Lu C, Huang PJ, Liu B et al (2016) Comparison of graphene oxide and reduced graphene oxide for dna adsorption and sensing. Langmuir 32:10776–10783
Luo L, Xu L, Zhao H (2017) Biosynthesis of reduced graphene oxide and its in-vitro cytotoxicity against cervical cancer (HeLa) cell lines. Mater Sci Eng C Mater Biol Appl 78:198–202
Luo Y, Tang Y, Liu T et al (2019) Engineering graphene oxide with ultrasmall SPIONs and smart drug release for cancer theranostics. Chem Commun 55:1963–1966
Ma H, Liu J, Ali MM et al (2015) Nucleic acid aptamers in cancer research, diagnosis and therapy. Chem Soc Rev 44:1240–1256
Mallick A, Nandi A, Basu S (2019) Polyethylenimine coated graphene oxide nanoparticles for targeting mitochondria in cancer cells. ACS Appl Bio Mater 2:14–19
Marketsandmarkets.com Report (2017) Graphene market worth 278.47 Million USD by 2020. http://www.marketsandmarketscom/PressReleases/grapheneasp
Mattos AJP, Raquel FE, Anna DR (2014) Gold nanoparticle mediated cancer immunotherapy. Nanomedicine 10:503–514
McNaught AD, Wilkinson A (1997) IUPAC. Compendium of chemical terminology, 2nd edn. Blackwell Scientific Publications, Oxford
Meghana S, Kabra P, Chakraborty S et al (2015) Understanding the pathway of antibacterial activity of copper oxide nanoparticles. RSC Adv 5:12293–12299
Millstone JE, Kavulak DF, Woo CH et al (2010) Synthesis, properties, and electronic applications of size-controlled poly(3-hexylthiophene) nanoparticles. Langmuir 26:13056–13061
Mittal S, Kumar V, Dhiman N et al (2016) Physico-chemical properties based differential toxicity of graphene oxide/reduced graphene oxide in human lung cells mediated through oxidative stress. Sci Rep 6:15860
Muazim K, Hussain Z (2017) Graphene oxide - a platform towards theranostics. Mater Sci Eng C Mater Biol Appl 76:1274–1288
Mukherjee S, Sushma V, Patra S et al (2012) Green chemistry approach for the synthesis and stabilization of biocompatible gold nanoparticles and their potential applications in cancer therapy. Nanotechnology 23:455103
Mukherjee S, Sriram P, Barui AK et al (2015) Graphene oxides show angiogenic properties. Adv Healthc Mater 4:1722–1732
Mulcahy N (2008) Cancer to become leading cause of death worldwide. Medscape
Nanda SS, Yi DK, Kim K (2016) Study of antibacterial mechanism of graphene oxide using Raman spectroscopy. Sci Rep 6:28443
Nejabat M, Charbgoo F, Ramezani M (2017) Graphene as multifunctional delivery platform in cancer therapy. J Biomed Mater Res A 105:2355–2367
Nguyen DT, Orgill DP, Murphy GF (2009) The pathophysiologic basis for wound healing and cutaneous regeneration, Biomaterials for treating skin loss. Woodhead Publishing, Boca Raton, pp 25–57
Nicol W (2015) A material supreme: how graphene will shape the world of tomorrow digital trends
Nie W, Peng C, Zhou X et al (2017) Three-dimensional porous scaffold by self-assembly of reduced graphene oxide and nano-hydroxyapatite composites for bone tissue engineering. Carbon 116:325–337
Nolan CP, DeAngelis LM (2015) Neurologic complications of chemotherapy and radiation therapy. Continuum (Minneap Minn) 21:429–451
Novoselov KS, Geim AK, Morozov SV et al (2004) Electric field effect in atomically thin carbon films. Science 306:666–669
Nurunnabi M, Parvez K, Nafiujjaman M et al (2015) Bioapplication of graphene oxide derivatives: drug/gene delivery, imaging, polymeric modification, toxicology, therapeutics and challenges. RSC Adv 5:42141–42161
Orecchioni M, Cabizza R, Bianco A et al (2015) Graphene as cancer theranostic tool: progress and future challenges. Theranostics 5:710–723
Orecchioni M, Jasim DA, Pescatori M et al (2016a) Molecular and genomic impact of large and small lateral dimension graphene oxide sheets on human immune cells from healthy donors. Adv Healthc Mater 5:276–287
Orecchioni M, Menard-Moyon C, Delogu LG et al (2016b) Graphene and the immune system: challenges and potentiality. Adv Drug Deliv Rev 105:163–175
Ou LL, Song B, Liang H et al (2016) Toxicity of graphene-family nanoparticles: a general review of the origins and mechanisms. Part Fibre Toxicol 13:57
Ouay LB, Stellacci F (2015) Antibacterial activity of silver nanoparticles: a surface science insight. Nano Today 10:339–354
Park J, Kim YS, Ryu S et al (2015) Graphene potentiates the myocardial repair efficacy of mesenchymal stem cells by stimulating the expression of angiogenic growth factors and gap junction protein. Adv Func Mater 25:2590–2600
Patra CR (2015) Graphene oxides and the angiogenic process. Nanomedicine (Lond) 10:2959–2962
Patra CR, Bhattacharya R, Patra S et al (2008) Pro-angiogenic properties of europium(III) hydroxide nanorods. Adv Mater 20:753–756
Patra CR, Kim JH, Pramanik K et al (2011) Reactive oxygen species driven angiogenesis by inorganic nanorods. Nano Lett 11:4932–4938
Paul A, Hasan A, Kindi HA et al (2014) Injectable graphene oxide/hydrogel-based angiogenic gene delivery system for vasculogenesis and cardiac repair. ACS Nano 8:8050–8062
Perreault F, de Faria AF, Nejati S et al (2015) Antimicrobial properties of graphene oxide nanosheets: why size matters. ACS Nano 9:7226–7236
Rahman M, Akhter S, Ahmad MZ et al (2015) Emerging advances in cancer nanotheranostics with graphene nanocomposites: opportunities and challenges. Nanomedicine 10:2405–2422
Raj S, Jose S, Sumod US et al (2012) Nanotechnology in cosmetics: opportunities and challenges. J Pharm Bioallied Sci 4:186–193
Ren L, Zhang Y, Cui C et al (2017) Functionalized graphene oxide for anti-VEGF siRNA delivery: preparation, characterization and evaluation in vitro and in vivo. RSC Adv 7:20553–20566
Report B (2014) Autumn statement 2014: Manchester to get £235m science research centre. http://www.bbccom/news/uk-england-30309451
Report D (2016) Graphene: research now, reap next decade. https://www2.deloitte.com/global/en/pages/technology-media-and-telecommunications/articles/tmt-pred16-tech-graphene-research-now-reap-next-decade.html
Report Gc (2017) Graphene market Size and trend analysis by product (Nanoplatelets, Oxide), by application (Electronics, Composites, Energy), by region (North America, Europe, Asia Pacific, Rest of the World), and Segment forecasts, 2014–2025. http://www.grandviewresearchcom/industry-analysis/graphene-industry
Rieger S, Zhao H, Martin P et al (2015) The role of nuclear hormone receptors in cutaneous wound repair. Cell Biochem Funct 33:1–13
Robinson JT, Tabakman SM, Liang YY et al (2011) Ultrasmall reduced graphene oxide with high near-infrared absorbance for photothermal therapy. J Am Chem Soc 133:6825–6831
Sahne F, Mohammadi M, Najafpour GD (2019) Single-layer assembly of multifunctional carboxymethylcellulose on graphene oxide nanoparticles for improving in vivo curcumin delivery into tumor cells. ACS Biomater Sci Eng 5(5):2595–2609
Sahu SC, Casciano DA (eds) (2009) Nanotoxicity: from in vivo and in vitro models to health risks. Wiley, Chichester
Schaefer H-E (2010) Nanoscience. The science of the small in physics, engineering, chemistry, biology and medicine. Springer, New York
Schafhaeutl C (1840) LXXXVI. On the combinations of carbon with silicon and iron, and other metals, forming the different species of cast iron, steel, and malleable iron. London, Edinburgh, Dublin Philos Mag J Sci 16:570–590
Shi S, Yang K, Hong H et al (2013) Tumor vasculature targeting and PET imaging in living mice with reduced graphene oxide. Eur J Nucl Med Mol Imaging 40:S153–S153
Shim G, Kim JY, Han J et al (2014) Reduced graphene oxide nanosheets coated with an anti-angiogenic anticancer low-molecular-weight heparin derivative for delivery of anticancer drugs. J Control Release 189:80–89
Shin SR, Li YC, Jang HL et al (2016a) Graphene-based materials for tissue engineering. Adv Drug Deliv Rev 105:255–274
Shin SR, Zihlmann C, Akbari M et al (2016b) Reduced graphene oxide-GelMA hybrid hydrogels as scaffolds for cardiac tissue engineering. Small 12:3677–3689
Steichen SD, Caldorera-Moore M, Peppas NA (2013) A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics. Eur J Pharm Sci 48:416–427
Su SH, Wang JL, Wei JH et al (2015) Efficient photothermal therapy of brain cancer through porphyrin functionalized graphene oxide. New J Chem 39:5743–5749
Sun X, Liu Z, Welsher K et al (2008) Nano-graphene oxide for cellular imaging and drug delivery. Nano Res 1:203–212
Sun ZC, Huang P, Tong G et al (2013) VEGF-loaded graphene oxide as theranostics for multi-modality imaging-monitored targeting therapeutic angiogenesis of ischemic muscle. Nanoscale 5:6857–6866
Sun X, Zebibula A, Dong X et al (2018) Aggregation-induced emission nanoparticles encapsulated with PEGylated nano graphene oxide and their applications in two-photon fluorescence bioimaging and photodynamic therapy in vitro and in vivo. ACS Appl Mater Interfaces 10:25037–25046
Syama S, Paul W, Sabareeswaran A et al (2017) Raman spectroscopy for the detection of organ distribution and clearance of PEGylated reduced graphene oxide and biological consequences. Biomaterials 131:121–130
Tan YB, Lee JM (2013) Graphene for supercapacitor applications. J Mater Chem A 1:14814–14843
Tang P, Han L, Li P et al (2019) Mussel-inspired electroactive and antioxidative scaffolds with incorporation of polydopamine-reduced graphene oxide for enhancing skin wound healing. ACS Appl Mater Interfaces 11:7703–7714
Tao Y, Ju EG, Ren JS, Qu XG (2014) Immunostimulatory oligonucleotides-loaded cationic graphene oxide with photothermally enhanced immunogenicity for photothermal/immune cancer therapy. Biomaterials 35:9963–9971
Teli MK, Mutalik S, Rajanikant GK (2010) Nanotechnology and nanomedicine: going small means aiming big. Curr Pharm Des 16:1882–1892
Thangavel P, Kannan R, Ramachandran B et al (2018) Development of reduced graphene oxide (rGO)-isabgol nanocomposite dressings for enhanced vascularization and accelerated wound healing in normal and diabetic rats. J Colloid Interface Sci 517:251–264
Tian J, Luo Y, Huang L et al (2016) Pegylated folate and peptide-decorated graphene oxide nanovehicle for in vivo targeted delivery of anticancer drugs and therapeutic self-monitoring. Biosens Bioelectron 80:519–524
Torchilin VP (2010) Passive and active drug targeting: drug delivery to tumors as an example. Handb Exp Pharmacol 197:50
Tran TH, Nguyen HT, Pham TT et al (2015) Development of a graphene oxide nanocarrier for dual-drug chemo-phototherapy to overcome drug resistance in cancer. ACS Appl Mater Interfaces 7:28647–28655
Velnar T, Bailey T, Smrkolj V (2009) The wound healing process: an overview of the cellular and molecular mechanisms. J Int Med Res 37:1528–1542
Wang Y, Hu R, Lin G et al (2013) Functionalized quantum dots for biosensing and bioimaging and concerns on toxicity. ACS Appl Mater Interfaces 5:2786–2799
Wei Y, Zhou F, Zhang D et al (2016) A graphene oxide based smart drug delivery system for tumor mitochondria-targeting photodynamic therapy. Nanoscale 8:3530–3538
Wierzbicki M, Sawosz E, Grodzik M et al (2013) Comparison of anti-angiogenic properties of pristine carbon nanoparticles. Nanoscale Res Lett 8:195
Winter JO (2007) Nanoparticles and nanowires for cellular engineering. Nanotechnologies for the life sciences. Wiley, New York
Wu CH, He QM, Zhu AN et al (2014) Synergistic anticancer activity of photo- and chemoresponsive nanoformulation based on polylysine-functionalized graphene. ACS Appl Mater Interfaces 6:21615–21623
Wu SY, An SS, Hulme J (2015) Current applications of graphene oxide in nanomedicine. Int J Nanomedicine 10(Spec Iss):9–24
Xing FY, Guan LL, Li YL et al (2016) Biosynthesis of reduced graphene oxide nanosheets and their in vitro cytotoxicity against cardiac cell lines of Catla catla. Environ Toxicol Pharmacol 48:110–115
Xu LG, Xiang J, Liu Y et al (2016) Functionalized graphene oxide serves as a novel vaccine nano-adjuvant for robust stimulation of cellular immunity. Nanoscale 8:3785–3795
Xu X, Tang X, Wu X et al (2019) Biosynthesis of sorafenib coated graphene nanosheets for the treatment of gastric cancer in patients in nursing care. J Photochem Photobiol B 191:1–5
Yaacoub K, Pedeux R, Tarte K et al (2016) Role of the tumor microenvironment in regulating apoptosis and cancer progression. Cancer Lett 378:150–159
Yadav N, Kumar N, Prasad P et al (2018) Stable dispersions of covalently tethered polymer improved graphene oxide nanoconjugates as an effective vector for siRNA delivery. ACS Appl Mater Interfaces 10:14577–14593
Yan M, Liu Y, Zhu X et al (2019) Nanoscale reduced graphene oxide-mediated photothermal therapy together with IDO inhibition and PD-L1 blockade synergistically promote antitumor immunity. ACS Appl Mater Interfaces 11:1876–1885
Yang XY, Zhang XY, Liu ZF et al (2008) High-efficiency loading and controlled release of doxorubicin hydrochloride on graphene oxide. J Phys Chem C 112:17554–17558
Yang K, Wan JM, Zhang SA et al (2011) In vivo pharmacokinetics, long-term biodistribution, and toxicology of PEGylated graphene in mice. ACS Nano 5:516–522
Yang K, Wan JM, Zhang S et al (2012) The influence of surface chemistry and size of nanoscale graphene oxide on photothermal therapy of cancer using ultra-low laser power. Biomaterials 33:2206–2214
Yang K, Gong H, Shi XZ et al (2013) In vivo biodistribution and toxicology of functionalized nano-graphene oxide in mice after oral and intraperitoneal administration. Biomaterials 34:2787–2795
Yang DZ, Feng L, Dougherty CA et al (2016) In vivo targeting of metastatic breast cancer via tumor vasculature-specific nano-graphene oxide. Biomaterials 104:361–371
Yin F, Hu K, Chen Y et al (2017) SiRNA delivery with PEGylated graphene oxide nanosheets for combined photothermal and genetherapy for pancreatic cancer. Theranostics 7:1133–1148
Yoshioka Y, Higashisaka K, Tsunoda S, Tsutsumi Y (2014) The absorption, distribution, metabolism, and excretion profile of nanoparticles. In: Akashi M, Akagi T, Matsusaki M (eds) Engineered cell manipulation for biomedical application. Nanomedicine and nanotoxicology. Springer, Tokyo, pp 259–271
You DG, Deepagan VG, Um W et al (2016) ROS-generating TiO2 nanoparticles for non-invasive sonodynamic therapy of cancer. Sci Rep 6:23200
Yue H, Wei W, Gu Z et al (2015) Exploration of graphene oxide as an intelligent platform for cancer vaccines. Nanoscale 7:19949–19957
Yue H, Zhou X, Cheng M et al (2018) Graphene oxide-mediated Cas9/sgRNA delivery for efficient genome editing. Nanoscale 10:1063–1071
Zang Z, Zeng X, Wang M et al (2017) Tunable photoluminescence of water-soluble AgInZnS-graphene oxide (GO) nanocompositesand their application in-vivo bioimaging. Sens Actuators B Chem 252:1179–1186
Zare-Zardini H, Taheri-Kafrani A, Amiri A et al (2018) New generation of drug delivery systems based on ginsenoside Rh2-, Lysine- and Arginine-treated highly porous graphene for improving anticancer activity. Sci Rep 8:586
Zhang LM, Lu ZX, Zhao QH et al (2011) Enhanced chemotherapy efficacy by sequential delivery of siRNA and anticancer drugs using PEI-grafted graphene oxide. Small 7:460–464
Zhang M, Kim JA, Huang AYC (2018) Optimizing tumor microenvironment for cancer immunotherapy: β-Glucan-based nanoparticles. Front Immunol 9:341–341
Zhao X, Yang L, Li X et al (2015) Functionalized graphene oxide nanoparticles for cancer cell-specific delivery of antitumor drug. Bioconjug Chem 26:128–136
Zhao H, Osborne OJ, Lin S et al (2016) Lanthanide hydroxide nanoparticles induce angiogenesis via ROS-sensitive signaling. Small 12:4404–4411
Zhou Y, Chen R, He T et al (2016) Biomedical potential of ultrafine Ag/AgCl nanoparticles coated on graphene with special reference to antimicrobial performances and burn wound healing. ACS Appl Mater Interfaces 8:15067–15075
Zhu X, Xu X, Liu F et al (2017) Green synthesis of graphene nanosheets and their in vitro cytotoxicity against human prostate cancer (DU 145) cell lines. Nanomater Nanotechnol 7. https://doi.org/10.1177/1847980417702794
Zou L, Wang H, He B et al (2016) Current approaches of photothermal therapy in treating cancer metastasis with nanotherapeutics. Theranostics 6:762–772
Zurutuza A, Marinelli C (2014) Challenges and opportunities in graphene commercialization. Nat Nanotechnol 9:730–734
Acknowledgement
CRP is grateful to DST-Nanomission, New Delhi, (SR/NM/NS-1252/2013; GAP 570) for financial support. This book chapter is partially supported by ‘CSIR-Mayo Clinic Collaboration for Innovation and Translational Research’ (CKM/CMPP-09; MLP0020) fund from CSIR, New Delhi and 12th Five Year Plan (FYP) projects (ADD: CSC0302) CSIR, New Delhi, to CRP. A.K.B. and S.D. are thankful to UGC, New Delhi while A.R. and K.B. are thankful to ICMR, New Delhi, for their fellowships. The authors are thankful to the Director, CSIR-IICT for his support and encouragement and for his keen interest in this work. IICT manuscript communication number IICT/Pubs./2019/147 dated April 15, 2019 for this manuscript is duly acknowledged.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Barui, A.K., Roy, A., Das, S., Bhamidipati, K., Patra, C.R. (2020). Therapeutic Applications of Graphene Oxides in Angiogenesis and Cancers. In: Shukla, A. (eds) Nanoparticles and their Biomedical Applications. Springer, Singapore. https://doi.org/10.1007/978-981-15-0391-7_6
Download citation
DOI: https://doi.org/10.1007/978-981-15-0391-7_6
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-0390-0
Online ISBN: 978-981-15-0391-7
eBook Packages: MedicineMedicine (R0)